IVDAW — what changed in the latest 10-Q
A section-by-section comparison of IVDAW's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-15 vs the prior 10-Q · 2025-11-14
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +7 | −14 | ~7 | 50 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~3 | 7 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Other information | Text added/removed | 0 | 0 | ~1 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-15
Three Months Ended March 31, 2026 Three Months Ended March 31, 2025 Three Months Ended March 31, 2026
As of March 31, 2026, we had cash and cash equivalents of $5.7 million compared to $5.2 million as of December 31, 2025. This increase in our cash and cash equivalents for the three months ended March 31, 2026 is related to the sale of common stock offset by the operating losses during the three mon…
Net cash used in operating activities during the three months ended March 31, 2026 was ($0.9) million compared to ($0.1) million net cash used during the three months ended March 31, 2025. Net cash used in operating activities for the three months ended March 31, 2026 consisted primarily of the net …
Net cash used in investing activities for the three months ended March 31, 2026 and 2024 were negligible.
Net cash provided by financing activities for the three months ended March 31, 2026 were $1.4 million compared with $0 million provided during the three months ended March 31, 2025. Net cash provided by financing activities in 2026 included $1.6 million from the sale of stock in a direct offering ma…
Text removed vs the prior filing · source: 10-Q · 2025-11-14
Results of Operations for the Nine months ended September 30, 2025 Compared with the Nine months ended September 30, 2024
The table below sets forth the Net Revenue, Cost of Goods Sold, Operating Expenses, Other Income and Expenses, Tax Expense and Net Income by segment for each of the respective periods and a comparison period over period.
Consolidated US Taiwan Consolidated US Taiwan Consolidated US Taiwan
The increase in revenue for the nine months ended September 30, 2025 compared with the same period in 2024 is attributable primarily to increased equipment sales from Iveda Taiwan as a result of delivery timing related to long-term government contracts and increased US revenues through its distribut…
The overall gross margin had a slight increase attributed to the higher margin contract sales in the US and Taiwan.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice